Skip to content

Xencor XNCR Accretion (Amortization) of Discounts and Premiums, Investments

Accretion (Amortization) of Discounts and Premiums, Investments at other companies

Janux Therapeutics logo
Janux TherapeuticsJANX
$2.62M-37.8%
Absci Corporation logo
Absci CorporationABSI
$421K-39.8%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$106K
Summit Therapeutics logo
Summit TherapeuticsSMMT
$4.22M+42.2%
MBX Biosciences, Inc. logo
MBX Biosciences, Inc.MBX
$579K-56.9%
Precigen logo
PrecigenPGEN
$369K-47.7%

Other financials

Income statement

See full
Revenue$4.5M-86.2%
Operating income-$77.9M-80.3%
Net income-$128.9M-166%
EPS (diluted)-$1.71-159%

Balance sheet

See full
Cash & equivalents$14.2M-64.3%
Total debt$175.2M-21.2%
Total equity$515.6M-19.4%
Total assets$736.8M-18.6%

Cash flow

See full
Operating cash flow-$67.6M-317%
CapEx$610.0K-57.8%
Free cash flow-$68.2M-286%

Valuation

See full
Market cap$1.07B+76.3%
Enterprise value$1.23B+55.9%
P/S11×+6.2×

Profitability

See full
Operating margin-217.9%+425pp
Net margin-177.1%+16.5pp
FCF margin-194%+166pp

Returns & leverage

See full
Return on equity-29.8%-2.7pp
Debt / equity0.3×0.0×
Current ratio6.6×+0.7×

Where this comes from

Reported directly by Xencor in its filing.

Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.

The official record: Xencor’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xencor's accretion (amortization) of discounts and premiums, investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xencor's accretion (amortization) of discounts and premiums, investments?
Xencor (XNCR) reported accretion (amortization) of discounts and premiums, investments of $128K in Q1 2026.
How has Xencor's accretion (amortization) of discounts and premiums, investments changed year-over-year?
Xencor's accretion (amortization) of discounts and premiums, investments decreased by 94.0% year-over-year, from $2.13M to $128K.
What is the long-term trend for Xencor's accretion (amortization) of discounts and premiums, investments?
Over 2 years (2021 to 2024), Xencor's accretion (amortization) of discounts and premiums, investments has grown at a 129.4% compound annual growth rate (CAGR), from -$3.16M to $16.64M.
What does accretion (amortization) of discounts and premiums, investments mean?
This represents the non-cash adjustment to interest income or expense resulting from the amortization of premiums or accretion of discounts on debt securities held as investments. It reflects the gradual adjustment of the carrying value of investment securities toward their face value over time. Investors use this to reconcile the difference between the stated coupon rate and the effective yield of the investment portfolio.